v3.21.2
Condensed Consolidated Statements Of Changes In Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows provided by (used in) operating activities:    
Net income (loss) $ (84,014) $ (17,764)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 9,190 6,945
Loss on asset disposal 0 2
Equity-based compensation 20,642 2,789
Warrant liabilities 12,796 444
Amortization of revolver loan costs 558 0
Changes in operating assets and liabilities:    
Accounts receivable (3,009) 733
Prepaid expenses and other assets (3,818) 3,323
Prepaid revenue share fee (3,445) 2,595
Accounts payable 2,796 (1,572)
Accrued liabilities 28,615 (4,998)
Deferred revenue 58,047 (21,653)
Deferred rent (381) 685
Net cash used provided by (used in) operating activities 37,977 (28,471)
Cash flows used in investing activities:    
Purchases of marketable debt securities (689,789) (104,249)
Sales of marketable debt securities 392,066 99,898
Issuance of loan 0 (250)
Purchases of property and equipment (22,042) (9,181)
Capitalized intangible assets (713) (425)
Net cash used in investing activities (320,478) (14,207)
Cash flows provided by (used in) financing activities:    
IPO proceeds, net of underwriter fees and issuance costs 437,494 0
Repurchase of members’ equity (11,744) (210,310)
Proceeds from issuance of members’ equity, net of cost 80,277 113,944
Distribution to post-reorganization members (4,128) 0
Issuance of warrants 289 0
Proceeds from the exercise of warrants 2,575 0
Payment of revolver loan costs (718) (652)
Net cash provided by (used in) financing activities 504,045 (97,018)
Net increase (decrease) in cash, cash equivalents, and restricted cash 221,544 (139,696)
Cash, cash equivalents, and restricted cash, beginning of period 139,082 236,051
Cash, cash equivalents, and restricted cash, end of period $ 360,626 $ 96,355

Source